Gold R, Radue EW, Giovannoni G, Selmaj K, et al. Long-term safety and efficacy of daclizumab beta in relapsing-remitting multiple
sclerosis: 6-year results from the SELECTED open-label extension study. J Neurol 2020 May 25. pii: 10.1007/s00415-020-09835.
PMID: 32451615